Damon Runyon Cancer Research Foundation: New Cellular Immunotherapy Shows Promise Against Solid Tumors
October 27, 2026
October 27, 2026
NEW YORK, Oct. 27 (TNSjou) -- The Damon Runyon Cancer Research Foundation issued the following news release:
* * *
New cellular immunotherapy shows promise against solid tumors
October 26, 2026
Since the first FDA approval nearly a decade ago of a chimeric antigen receptor (CAR) T cell therapy, in which a patient's own immune cells are genetically engineered to recognize and attack their cancer, scientists have been trying to design next-g . . .
* * *
New cellular immunotherapy shows promise against solid tumors
October 26, 2026
Since the first FDA approval nearly a decade ago of a chimeric antigen receptor (CAR) T cell therapy, in which a patient's own immune cells are genetically engineered to recognize and attack their cancer, scientists have been trying to design next-g . . .